Dopamine-dependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease

Alam, 2002, Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats, Behav. Brain Res., 136, 317, 10.1016/S0166-4328(02)00180-8 Ascherio, 2006, Pesticide exposure and risk for Parkinson's disease, Ann. Neurol., 60, 197, 10.1002/ana.20904 Auluck, 2002, Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease, Science, 295, 865, 10.1126/science.1067389 Barolo, 2000, GFP and beta-galactosidase transformation vectors for promoter/enhancer analysis in Drosophila, Biotechniques, 29, 726, 10.2144/00294bm10 Betarbet, 2000, Chronic systemic pesticide exposure reproduces features of Parkinson's disease, Nat. Neurosci., 3, 1301, 10.1038/81834 Botella, 2008, Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease, Neurobiol. Dis., 30, 65, 10.1016/j.nbd.2007.11.013 Bové, 2005, Toxin-induced models of Parkinson's disease, NeuroRx, 2, 484, 10.1602/neurorx.2.3.484 Brown, 2006, Pesticides and Parkinson's disease—is there a link?, Environ. Health Perspect., 114, 156, 10.1289/ehp.8095 Bywood, 2003, Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices, Exp. Neurol., 179, 47, 10.1006/exnr.2002.8044 Coulom, 2004, Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster, J. Neurosci., 24, 10993, 10.1523/JNEUROSCI.2993-04.2004 Dietzl, 2007, A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila, Nature, 448, 151, 10.1038/nature05954 Dukes, 2005, The effect of endogenous dopamine in rotenone-induced toxicity in PC12 cells, Antioxid. Redox Signal., 7, 630, 10.1089/ars.2005.7.630 Feany, 2000, A Drosophila model of Parkinson's disease, Nature, 404, 394, 10.1038/35006074 Friggi-Grelin, 2003, Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase, J. Neurobiol., 54, 618, 10.1002/neu.10185 Kruger, 1998, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet., 18, 106, 10.1038/ng0298-106 Liu, Q., Rand, T.A., Kalidas, S., Du, F., Kim, H.E., Smith, D.P., Wang, X., 2003. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway. Science 26, 1921–1925. Liu, 2005, Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells, Acta Pharmacol. Sin., 26, 17, 10.1111/j.1745-7254.2005.00003.x Lotharius, 2002, Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease, Hum. Mol. Genet., 11, 2395, 10.1093/hmg/11.20.2395 Neckameyer, 1996, Multiple roles for dopamine in Drosophila development, Dev. Biol., 176, 209, 10.1006/dbio.1996.0128 Outeiro, 2007, Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease, Science, 317, 516, 10.1126/science.1143780 Park, 2007, Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein, Eur. J. Neurosci., 26, 3104, 10.1111/j.1460-9568.2007.05929.x Polymeropoulos, 1997, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, 276, 2045, 10.1126/science.276.5321.2045 Robinow, 1988, Characterization and spatial distribution of the ELAV protein during Drosophila melanogaster development, J. Neurobiol., 22, 443, 10.1002/neu.480220503 Rochet, 2004, Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease, J. Mol. Neurosci., 23, 23, 10.1385/JMN:23:1-2:023 Sakka, 2003, Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone, Neuroreport, 14, 2425, 10.1097/00001756-200312190-00027 Sang, 2007, A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine, J. Neurosci., 27, 981, 10.1523/JNEUROSCI.4810-06.2007 Sherer, 2003, Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation, Exp. Neurol., 179, 9, 10.1006/exnr.2002.8072 Singleton, 2003, alpha-Synuclein locus triplication causes Parkinson's disease, Science, 302, 841, 10.1126/science.1090278 Takeda, 2006, Mechanisms of neuronal death in synucleinopathy, J. Biomed. Biotechnol., 2006, 19365, 10.1155/JBB/2006/19365 Testa, 2005, Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures, Brain Res. Mol. Brain Res., 134, 109, 10.1016/j.molbrainres.2004.11.007 True, 1999, Drosophila wing melanin patterns form by vein-dependent elaboration of enzymatic prepatterns, Curr. Biol., 9, 1382, 10.1016/S0960-9822(00)80083-4 Watabe, 2007, Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells, J. Pharmacol. Exp. Ther., 323, 499, 10.1124/jpet.107.127597 Whitworth, 2005, Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease, Proc. Natl. Acad. Sci. U. S. A., 102, 8024, 10.1073/pnas.0501078102 Xu, 2002, Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease, Nat. Med., 8, 600, 10.1038/nm0602-600 Yu, 2005, Alpha-synuclein and dopamine metabolism, Mol. Neurobiol., 31, 243, 10.1385/MN:31:1-3:243